Abstract
Isobaric tags for relative and absolute quantification (iTRAQ) is a stable isotope method for protein measurement by using mass spectrometry (Ross et al., 2004). It can be used for the comparison of four or eight different samples at the same time (Ross et al., 2004; Pierce et al., 2008) and can be used to examine the proteomic profiles before and after virus infection. For example, in this study, we applied iTRAQ to quantitatively profile the proteomes of SGIV-infected and non-infected grouper embryonic cells (GEC). This is the first study on the iridovirus and host interactions at the proteomics scale. Forty-nine viral proteins were identified and 11 of them are reported for the first time. Furthermore, 743 protein entries of the host were identified and classified into 218 groups based on protein functions. The host proteins affected by SGIV infection are discussed further. Our work should significantly contribute to the understanding of host–pathogen interactions.
Cell and virus infection.GEC, from brown-spotted grouper Epinephelus tauvina (Chew et al., 1994), were cultured in Eagle's minimum essential medium containing 10 % fetal bovine serum, 0.116 M NaCl, 100 IU penicillin G ml–1 and 100 µl streptomycin sulfate ml–1. The culture media were equilibrated with HEPES to a final concentration of 5 mM and adjusted to pH 7.4 with NaHCO3. GEC were infected with SGIV at an m.o.i of 5. In this experiment, SGIV-infected GEC were harvested 48 h post-infection to ensure almost all the host cells were infected by the virus.
iTRAQ labelling and two dimensional (2D) LC-MALDI MS.
The non-infected and infected cells (48 h post-infection of SGIV) were lysed with lysis buffer (0.5 M triethylammonium bicarbonate, pH 8.5, 1 % SDS). One hundred micrograms of total protein from each sample of cell lysate was used for the iTRAQ experiment. Four unique iTRAQ reagents were used: 114, 115, 116 and 117, which are named based on the molecular mass (Da) of the reporter ions in each reagent. The iTRAQ principles have been described by Ross et al. (2004).
Briefly, the proteins were reduced and cysteine blocked according to protocol of the iTRAQ kit (Applied Biosystems). Then, samples were diluted 10 times with 0.5 M triethylammonium bicarbonate, pH 8.5. Each sample was incubated with 25 µl of 1 µg trypsin (Applied Biosystems) µl–1 at 37 °C overnight. The samples were vacuum-dried and reconstituted with 30 µl 0.5 M triethylammonium bicarbonate, pH 8.5. The proteins from the non-infected and SGIV-infected cells were labelled with iTRAQ reagents 114 and 115, respectively. The labelled samples were pooled and purified using a strong cation exchange column (Applied Biosystems). The bound peptides were eluted with 5 % NH4OH in 30 % methanol.
After drying, the iTRAQ-labelled peptides were resuspended in 20 µl 5 mM KH2PO4 buffer containing 5 % acetonitrile, pH 3.0, and separated by 2D-Liquid Chromatography (2D-LC) using an Ultimate dual-gradient LC system (Dionex-LC Packings), as described previously (Li et al., 2007).
The LC fractions were analysed by using an ABI 4700 Proteomics Analyser MALDI TOF/TOF mass spectrometer (Applied Biosystems). GPS Explorer software version 3.5 (Applied Biosystems) employing MASCOT search engine (version 2.1; Matrix Science) was used for peptide and protein identifications and iTRAQ quantification. The NCBI database was used for the search. Cysteine methane thiolation, N-terminal iTRAQ labelling and iTRAQ-labelled lysine were selected as fixed modifications during iTRAQ data analysis (Zieske, 2006).
RT-PCR.
Total RNA was extracted from infected cell culture at late stage (48 h post-infection) using an RNeasy mini kit (Qiagen). The extracted RNA was treated with RNase-free DNase I (Qiagen). RT-PCR was conducted as described in the One-Step RT-PCR kit (Qiagen) protocol using treated RNA and gene-specific primers. Briefly, in the reverse transcription step cDNA was synthesized from total RNA at 50 °C for 30 min. Reverse transcriptase was inactivated by a heating step at 95 °C for 15 min. The PCR amplification of target genes was started after activation of the HotStarTaq DNA polymerase. The amplification reactions were carried out for 30 cycles under conditions of 95 °C for 30 s, annealing temperature of 55 or 58 °C for 30 s (Supplementary Table S1 available in JGV Online) and 72 °C for 1.5 min per cycle. The RT-PCR products were then analysed on a 1.2 % agarose gel.
Western blot analysis.
Infected cells (48 h post-infection) and non-infected cells (for control) were harvested. The cell lysate was treated with 5x SDS loading dye and boiled for 10 min. The proteins were fractionated by SDS-PAGE on a 15 % gel and blotted onto a nitrocellulose membrane (Amersham) in blotting buffer (3.205 g Tris base, 14.25 g glycine and 200 ml methanol per litre) for 1 h at 70 V. The blotted membrane was then blocked in 5 % skimmed milk, 1 % BSA in TBST (20 mM Tris pH 7.4, 154 mM NaCl, 0.1 % Tween 20) for 1 h and washed three times for 10 min with TBST. The membranes were incubated with the primary antibodies (different dilution for each antibodies) for 1 h and washed three times for 10 min with TBST, treated with secondary antibodies for 1 h, then washed three times for 10 min. After that, the membranes were treated with a mixture of Super Signal West Pico Stable Peroxide Solution and luminol enhancer solution (Pierce) for 5 min and then exposed to X-ray films for image development.
In addition, antibodies for proteins encoded by SGIV ORF18F, ORF26R, ORF135L and ORF140L were raised from New Zealand White female rabbits. The dilution factors for these antibodies for Western blot analysis were 1 : 5000, 1 : 1000, 1 : 300 and 1 : 5000, respectively. Only antibody for SGIV ORF93L protein was raised from mouse and the dilution factor for Western blot analysis was 1 : 500.
Identification of viral proteinsProteins of SGIV-infected GEC (48 h post-infection) and of the non-infected cells were extracted and prepared for iTRAQ. A total of 49 viral proteins were identified, in which 48 proteins were scored with more than 95 % of total ion score confidence interval percentage (CI %). Only ORF022L, which has been reported by Song et al. (2006), was identified at 86.351 CI %. Of these 49 proteins, 11 were discovered for the first time (Table 1), the remaining 38 proteins (Table 2) have been reported previously (Song et al., 2004, 2006). In addition, 10 of the 11 newly identified proteins, except ORF049L that is predicted to be a dUTPase-like protein (Song et al., 2004), are novel proteins with unknown functions.
Table 1. Eleven SGIV proteins that were newly identified by the iTRAQ experiment E, Early-stage viral gene; IE, immediate-early viral gene; L, late-stage viral gene; ?, unclassified viral gene.
Table 2. Thirty-eight SGIV proteins, which have been previously reported, were also identified by the iTRAQ experiment E, Early-stage viral gene; IE, immediate-early viral gene; L, late-stage viral gene; ?, unclassified viral gene.
RT-PCR and Western blot analysis of the viral proteins
The transcriptional products of the 11 ORFs, which corresponded to the 11 newly identified proteins, were examined by RT-PCR (primers are listed in Supplementary Table S1 available in JGV Online). These 11 ORFs have full-length transcriptional products as shown in Fig. 1.
|
In addition, the recombinant proteins of ORF018R, ORF026R, ORF093L, ORF135L and ORF140R were expressed, purified and used to raise antibodies. The Western blot showed the presence of these proteins in the infected GEC, and as expected, none in the non-infected GEC (Fig. 2).
|
Identification of differentially expressed host proteins
To investigate the host cell protein responses after SGIV infection, the iTRAQ data of non-infected GEC (as a control) and SGIV-infected cells were searched against the NCBI database. Of the 743 host proteins found, 726 proteins were identified with total ion score CI % ≥95 % (Supplementary Table S2 available in JGV Online). Twelve of them (total ion score CI % ≥95 %) were upregulated more than 1.5-fold upon virus infection (Table 3) and another five were downregulated more than 1.5-fold (Table 4).
Table 3. Twelve proteins from the host cells that were upregulated more than 1.5-fold upon SGIV infection
Table 4. Five proteins from the host cells that were downregulated more than 1.5-fold upon SGIV infection
Given that two upregulated proteins, matrix protein and putative head-tail adaptor, did not match to any of the 162 ORFs from SGIV genome, they were considered as host proteins.
Upregulation of host histone H3 lysine 79 (K79) methylation upon SGIV infection
This set of iTRAQ data showed that the host histone H3 was downregulated upon SGIV infection but did not indicate the histone modification status (Table 4). In fact, we did not include any variable modifications in the database search; hence, the result only illustrated that non-modified histone H3 was downregulated. The histone H3 peptide identified by iTRAQ was EIAQDFKTDLR, in which K (lysine) is the seventy-ninth amino acid residue. Histone H3 K79 methylation could occur at this position (Peterson & Laniel, 2004). Although the iTRAQ study only showed the non-modified form, a Western blot approach could enable us to examine the expression of total histone H3 and histone H3 K79 methylation. Western blot experiments were conducted for SGIV-infected and non-infected cell lysates using commercial anti-histone H3 antibody and anti-histone H3 K79 methylation antibody. The results demonstrated that histone H3 K79 methylation was upregulated upon virus infection, while total histone H3 remained unchanged (Fig. 3).
|
In the present investigation, 49 viral proteins were identified using iTRAQ analysis. Some of their encoded ORFs, such as ORF018R, ORF026R and ORF093L, were previously reported as full-length putative genes (Song et al., 2004). In this study, we were able to show using Western blot with specific antibodies that these ORFs encode full-length protein products (Fig. 2). Similarly, the ORFs of the 11 new proteins, first reported in this work, had full-length transcriptional products as evidenced by the RT-PCR results (Fig. 1). In addition, the translational products of ORF140R and 135L were validated by Western blot (Fig. 2), showing that these proteins were expressed in the cell culture.
Among the 49 SGIV viral proteins, only six proteins are predicted to contain conserved domains such as the dUTPase conserved domain (ORF049L), major capsid protein (ORF072R), tyrosine kinase (ORF081L), RNase III (ORF084L), putative immediate-early protein (ORF086R) and ubiquitin/ribosomal-like protein (ORF102L). The remaining 43 viral proteins have no homology to any known proteins. However, the functions of all these viral proteins would need to be determined further.
A total of 51 SGIV proteins was identified by Song et al. (2006); 38 of them were determined in this study. The reasons for the absence of the remaining 13 proteins in these iTRAQ data may be due to the technical differences between the two methods and the amount of samples used in these studies.
Viral infection causes differential expression of host proteins
Our iTRAQ study, in addition to the identification of novel and functional viral proteins, also provided important information on the differential expression of host proteins. The differential expression of host proteins is an indication of the responses of the host cell to SGIV infection. Twelve proteins of the host cell were upregulated upon SGIV infection (Table 3). The upregulation of host mucin-associated surface protein, an important factor in host innate immune system (Park et al., 2001; Sheehan et al., 2006), possibly provides the links in the host immune responses to viral infection. However, the downregulation of cellular Rho GTPase, an enzyme involved in complex mechanical processes such as cell motility and phagocytocis (Caron & Hall, 1998; Wherlock & Mellor, 2002), might help the virus to escape the host's macrophages.
Once inside a host cell, viruses hijack the host machinery by controlling or utilizing some of the host cell proteins for their own benefit (Williams et al., 2005). The cellular dihydrofolate synthase, involved in folic acid biosynthesis (Tettelin et al., 2005), was upregulated. Folic acid is one crucial element in DNA replication (Jennings, 1995) and its biosynthesis requires ATP as an energy source (Young, 1986). Interestingly, the ATP synthase F1 alpha subunit, which is involved in ATP synthesis-coupled proton transport (Leyva et al., 2003), showed an increased level of expression in SGIV-infected cells.
On the other hand, several host proteins were downregulated (Table 4). Chain A, rotamer strain as a determinant of protein structural specificity, was identified with the two peptide sequences, IQDKEGIPPDQQR and TLSDYNLQK. Chain A was designed as a variant of ubiquitin in the study of the impact of hydrophobic core packing on protein structure specificity (Lazar et al., 1999).
In cells, ubiquitin is synthesized as precursors of polyubiquitin chains or fusion proteins of monoubiquitin with S27a ribosomal protein (Finley et al., 1989; Redman & Rechsteiner, 1989). The iTRAQ results have shown the steady expression of the host polyubiquitin (Supplementary Table S2) and downregulation of S27a protein. It is possible that the host has two different ubiquitin sequences, one from the polyubiquitin chains and one from monoubiquitin–S27a fusion protein, which is identical to the chain A peptide sequence (Fig. 4). Furthermore, alpha-2-macroglobulin isoform 1, which participates in protease inhibition (Westwood et al., 2001), was upregulated in SGIV-infected GEC. It is likely that the virus can protect its proteins by inhibiting the host proteases and ubiquitin expression.
|
It has been reported that host cell protein synthesis was rapidly or selectively inhibited by virus infection (Kozak, 1986; Schneider & Shenk, 1987; Sonenberg, 1987). This phenomenon has been shown in cells infected by some iridoviruses such as Chilo iridescent virus (Cerutti & Devauchelle, 1980) and Frog virus 3 (Chinchar & Yu, 1992). In SGIV, the synthesis of host proteins was inhibited upon SGIV infection (data not shown). However, in this iTRAQ study, no host proteins were found to be completely shut off. This phenomenon would require further investigation once the grouper genome sequence is available.
Viral infection and host histone modification
Another interesting finding about the host protein expression upon SGIV infection is the downregulation of non-methylated histone H3. However, Western blot analysis (Fig. 3) revealed that methylated histone H3 K79 was upregulated and the level of both methylated and non-methylated histone H3 was the same after SGIV infection. As a result, the combination of upregulation of histone H3 K79 methylation and downregulation of non-modified histone H3 would make the total histone H3 expression stable.
Methylation of specific lysine residues in histone H3 was found to be closely related to the control of gene transcription (Tachibana et al., 2005). Recently, histone H3 K79 methylation was postulated as an important factor in DNA repair (Huyen et al., 2004) and leukaemic transformation (Okada et al., 2005). In SGIV-infected cells, histone H3 K79 methylation was found to be upregulated. However, the consequences of this event on gene activation or DNA repair are still not clear.
To our knowledge, this is the first study of SGIV and host cell relations at the proteomics scale. Eleven new viral proteins were identified. In addition, our data showed that expression levels of some host proteins were clearly regulated by the viral infection. These observations provide important information on SGIV–GEC interactions that could help to understand the pathogenesis of iridoviruses.
This work was financially supported by the Academic Research Fund Functional genomic studies of Singapore grouper iridovirus (T207B3106-RS) from the National University of Singapore to C. L. H.Footnotes
†,Supplementary tables are available with the online version of this paper.
References
Cerutti, M. & Devauchelle, G. (1980). Inhibition of macromolecular synthesis in cells infected with an invertebrate virus (iridovirus type 6 or CIV). Arch Virol 63, 297–303.[CrossRef][Medline]
Chen, L. M., Wang, F., Song, W. J. & Hew, C. L. (2006). Temporal and differential gene expression of Singapore grouper iridovirus. J Gen Virol 87, 2907–2915.
Chew, L. M., Ngoh, G. H., Ng, M. K., Lee, J. M., Chew, P., Li, J., Chan, Y. C. & Howe, J. L. C. (1994). Grouper cell line for propagating grouper viruses. Singap J Prim Ind 22, 113–116.
Chinchar, V. G. & Yu, W. (1992). Metabolism of host and viral mRNAs in frog virus 3-infected cells. Virology 186, 435–443.[CrossRef][Medline]
Chinchar, V. G., Essbauer, S., He, J. G., Hyatt, A., Miyazaki, T., Seligy, V. & Williams, T. (2005). Family Iridoviridae. In Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses, pp. 150–162. Edited by C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger & L. A. Ball. San Diego: Elsevier/Academic Press.
Chua, F. H. C., Ng, M. L., Ng, K. L., Loo, J. J. & Wee, J. Y. (1994). Investigation of outbreaks of a novel disease, sleepy grouper disease, the brown-spotted grouper, Epinephelus tauvina Forskal. J Fish Dis 17, 417–427.[CrossRef]
Finley, D., Bartel, B. & Varshavsky, A. (1989). The tails of ubiquitin precursors are ribosomal proteins whose fusion to ubiquitin facilitates ribosome biogenesis. Nature 338, 394–401.[CrossRef][Medline]
Huyen, Y., Zgheib, O., Ditullio, R. A. J., Gorgoulis, V. G., Zacharatos, P., Petty, T. J., Sheston, E. A., Mellert, H. S., Stavridi, E. S. & Halazonetis, T. D. (2004). Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature 432, 406–411.[CrossRef][Medline]
Jennings, E. (1995). Folic acid as a cancer preventing agent. Med Hypotheses 45, 297–303.[CrossRef][Medline]
Kozak, M. (1986). Regulation of protein synthesis in virus-infected cells. Adv Virus Res 31, 229–292.[Medline]
Lazar, G. A., Johnson, E. C., Desjarlais, J. R. & Handel, T. M. (1999). Rotamer strain as a determinant of protein structural specificity. Protein Sci 8, 2598–2610.[Medline]
Leyva, J. A., Bianchet, M. A. & Amzel, L. M. (2003). Understanding ATP synthesis: structure and mechanism of the F1-ATPase. Mol Membr Biol 20, 27–33.[CrossRef][Medline]
Li, Z., Lin, Q., Chen, J., Wu, J. L., Lim, T. K., Loh, S. S., Tang, X. & Hew, C. L. (2007). Shotgun identification of the structural proteome of shrimp white spot syndrome virus and iTRAQ differentiation of envelope and nucleocapsid subproteomes. Mol Cell Proteomics 6, 1609–1620.
Okada, Y., Feng, Q., Lin, Y., Jiang, Q., Li, Y., Coffield, V. M., Su, L., Xu, G. & Zhang, Y. (2005). hDOT1L links histone methylation to leukemogenesis. Cell 121, 167–178.[CrossRef][Medline]
Park, Y., Shin, C. Y., Lee, W. J., Jo, M. J., Ryu, J. R., Choi, E. Y., Kim, K. C. & Ko, K. H. (2001). Immunological characterization of a mucin-asscociated protein from hamster tracheal epithelial cell culture. Hybridoma 20, 123–129.[CrossRef][Medline]
Peterson, C. L. & Laniel, M. A. (2004). Histones and histone modifications. Curr Biol 14, R546–R551.[CrossRef][Medline]
Pierce, A., Unwin, R. D., Evans, C. A., Griffiths, S., Carney, L., Zhang, L., Jaworska, E., Lee, C. F., Blinco, D. & other authors (2008). Eight-channel iTRAQ enables comparison of the activity of 6 leukaemogenic tyrosine kinases. Mol Cell Proteomics 7, 853–863.
Qin, Q. W., Lam, T. J., Sin, Y. M., Shen, H., Chang, S. F., Ngoh, G. H. & Chen, C. L. (2001). Electron microscopic observations of a marine fish iridovirus isolated from brown-spotted grouper, Epinephelus tauvina. J Virol Methods 98, 17–24.[CrossRef][Medline]
Redman, K. L. & Rechsteiner, M. (1989). Identification of the long ubiquitin extension as ribosomal protein S27a. Nature 338, 438–440.[CrossRef][Medline]
Ross, P.L., Huang, Y.N., Marchese, J.N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S. & other authors (2004). Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3, 1154–1169.
Schneider, R. J. & Shenk, T. (1987). Impact of virus infection on host cell protein synthesis. Annu Rev Biochem 56, 317–332.[Medline]
Sheehan, J. K., Kesimer, M. & Pickles, R. (2006). Innate immunity and mucus structure and function. Novartis Found Symp 279, 155–166.[Medline]
Smith, K. M. & Xeros, N. (1954). An unusual virus disease of a dipterous larva. Nature 173, 866–867.[CrossRef][Medline]
Sonenberg, N. (1987). Regulation of translation by poliovirus. Adv Virus Res 33, 175–204.[Medline]
Song, W. J., Qin, Q. W., Qiu, J., Huang, C. H., Wang, F. & Hew, C. L. (2004). Functional genomics analysis of Singapore grouper iridovirus: complete sequence determination and proteomic analysis. J Virol 78, 12576–12590.
Song, W., Lin, Q., Joshi, S. B., Lim, T. K. & Hew, C. L. (2006). Proteomic studies of the Singapore grouper iridovirus. Mol Cell Proteomics 5, 256–264.
Tachibana, M., Ueda, J., Fukuda, M., Takeda, N., Ohta, T., Iwanari, H., Sakihama, T., Kodama, T., Hamakubo, T. & Shinkai, Y. (2005). Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev 19, 815–826.
Tettelin, H, Masignani, V., Cieslewicz, M. J., Donati, C., Medini, D, Ward, N. L., Angiuoli, S. V., Crabtree, J., Jones, A. L. & other authors (2005). Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial pan-genome. Proc Natl Acad Sci U S A 102, 13950–13955.
Westwood, M., Aplin, J. D., Collinge, I. A., White, A. & Gibson, J. M. (2001). Alpha 2-Macroglobulin: a new component in the insulin-like growth factor/insulin-like growth factor binding protein-1 axis. J Biol Chem 276, 41668–41674.
Wherlock, M. & Mellor, H. (2002). The Rho GTPase family: a Racs to Wrchs story. J Cell Sci 115, 239–240.
Williams, T. (1996). The iridoviruses. Adv Virus Res 46, 345–412.[Medline]
Williams, T., Barbosa-Solomieu, V. & Chinchar, V. G. (2005). A decade of advances in iridovirus research. Adv Virus Res 65, 173–248.[Medline]
Young, D. W. (1986). The biosynthesis of the vitamins thiamin, riboflavin and folic acid. Nat Prod Rep 3, 395–419.[CrossRef][Medline]
Zieske, L. R. (2006). A perspective on the use of iTRAQTM reagent technology for protein complex and profiling studies. J Exp Bot 57, 1501–1508.
Received 29 April 2008; accepted 7 July 2008.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |